STAT

NOVEMBER 28, 2023

Mayo Clinic will spend $5 billion to reinvent its flagship medical campus in Rochester, Minn., infusing digital technologies into several new buildings designed to present a 21st-century vision of clinical care, the organization said Tuesday. The project, to include five new buildings with 2.4 million square feet of space, will merge Mayo’s traditional medical services with its increasing investments in artificial intelligence and digital tools.

Mayo Clinic 364

Mayo Clinic Inpatient Hospitals 364

PharmaVoice

NOVEMBER 28, 2023

Cristina Durán, formerly AstraZeneca’s chief digital officer of R&D and now head of digital health spinoff Evinova, believes data will help pharma screen and treat patients earlier in their disease.

130

130

STAT

NOVEMBER 28, 2023

The Food and Drug Administration said Tuesday that it is investigating whether CAR-T therapy, which uses genetically modified white blood cells to attack tumors, can in rare cases cause lymphoma, a blood cancer. “Although the overall benefits of these products continue to outweigh their potential risks for their approved uses, FDA is investigating the identified risk of T cell malignancy with serious outcomes, including hospitalization and death, and is evaluating the need for regulatory

Hospitals 363

Hospitals 363

PharmaVoice

NOVEMBER 28, 2023

Despite one major outlier, 2023’s IPOs haven’t hit the heights of the past three years.

147

147

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Communication

STAT

NOVEMBER 28, 2023

Since the FDA’s approval of lecanemab (marketed as Leqembi) and Medicare’s recent decision to cover the drug, I have met with Alzheimer’s patients and their loved ones who are anxious to know whether they may benefit from this new treatment. They come in hope that this new medication may slow the progression of a cruel memory-robbing and personality-eroding disease.

360

360

BioPharma Dive

NOVEMBER 28, 2023

U.S. tax law changes enacted six years ago slashed large pharma companies' rates and saved them billions. Now, a push for an international floor could disrupt their R&D accounting.

126

126

BioPharma Dive

NOVEMBER 28, 2023

The agency said the benefit of approved treatments like Gilead’s Yescarta still outweighs any such risk, but the alert could slow drugmaker efforts to develop the treatments for wider use.

122

122

STAT

NOVEMBER 28, 2023

WASHINGTON — President Biden is using a Cold War-era law to stem drug shortages by boosting domestic pharmaceutical manufacturing. Biden announced the initiative at the first meeting of his supply chain resilience council. It’s based on a law, the Defense Production Act, that lets the government require private companies to make materials deemed necessary for national defense, in this case essential medicines and medical countermeasures.

Pharmaceutical Manufacturing 353

Pharmaceutical Manufacturing Hospitals 353

World Pharma News

NOVEMBER 28, 2023

The U.S. Food and Drug Administration approved Ogsiveo (nirogacestat) tablets for adult patients with progressing desmoid tumors who require systemic treatment. Ogsiveo is the first drug to be approved for the treatment of patients with desmoid tumors, a rare subtype of soft tissue sarcomas.

123

123

STAT

NOVEMBER 28, 2023

In response to strained budgets, a growing number of state and local governments across the U.S. are suing insulin makers and pharmacy benefit managers over claims the companies conspired to illegally drive up prices. In recent weeks, state officials in Utah and Arizona , and municipalities in New York, Virginia , Maryland, and Ohio have filed lawsuits alleging that the companies artificially drove up the cost of insulin, making the medication unaffordable for countless residents who have diabet

Diabetes 349

Diabetes 349

Advertisement

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

European Pharmaceutical Review

NOVEMBER 28, 2023

The US Food and Drug Administration (FDA) has approved the first drug for desmoid tumours (desmoid fibromatosis), an oral gamma secretase inhibitor. SpringWorks Therapeutics’ Ogsiveo (nirogacestat) tablets are authorised for adults with progressing desmoid tumours who require systemic treatment. A new treatment for desmoid tumours As a subtype of soft tissue sarcomas: “Desmoid tumours are rare [non-cancerous] tumours that can lead to severe pain and disability… [Ogsiveo is] the first approved tr

Labelling 104

Labelling 104

STAT

NOVEMBER 28, 2023

Vertex Pharmaceuticals is being accused by a group of advocates and physicians of refusing to take several steps that would widen access to its pricey cystic fibrosis medicines in predominantly poor countries. In a recent Zoom call, company executives were urged to drop patent claims and implement a global pricing model reflecting R&D and production costs, which could make the treatments more affordable.

Drug Pricing 328

Drug Pricing 328

The Pharmacist

NOVEMBER 28, 2023

Community Pharmacy England (CPE) has defended funding plans for the soon-to-launch Pharmacy First service after analysis by the Doctors’ Association UK (DAUK) suggested GPs would receive lower payments for consultations than pharmacists. In response to DAUK’s claim, Janet Morrison, chief executive of CPE, said there were ‘fundamental differences’ between how pharmacies and GPs are paid […] The post CPE hits back after doctors’ group cries foul over pharmacy funding appeared first on The Ph

Community Pharmacies 98

Community Pharmacies 98

STAT

NOVEMBER 28, 2023

Investors , analysts, doctors, and even patients face an avalanche of news from biotech companies about their human trials of experimental drugs, and wading through all that data to draw reasonable conclusions is a challenging task. This week, STAT has published a 2023 update of its Guide to Interpreting Clinical Trial Results, which can help consumers of company readouts navigate the process.

Drug Development 350

Drug Development 350

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

Pharma Times

NOVEMBER 28, 2023

Tafinlar and Mekinist led to a 56% overall response rate in children with BM-HGG - News - PharmaTimes

130

130

STAT

NOVEMBER 28, 2023

WASHINGTON — A top White House official on Tuesday delivered a pointed attack at a drugmaker fighting the administration’s Medicare negotiation plan in court. Christen Linke Young, White House Domestic Policy Council’s deputy assistant to the president for health and veterans affairs, took on Bristol-Myers Squibb, which makes the blockbuster blood thinner Eliquis.

Drug Pricing 294

Drug Pricing 294

European Pharmaceutical Review

NOVEMBER 28, 2023

Having been valued at $112 billion in 2022, the worldwide cold storage market is projected to witness a 12 percent compound annual growth rate (CAGR) between 2023 and 2032, according to a report by Towards Healthcare. Therefore, by the end of 2032, the market will value an estimated $383.05 billion, the research projected. Advancing cold storage for pharmaceuticals Temperature-sensitive pharmaceuticals requiring this type of storage include vaccines and biologics, the report explained.

Compounding 98

Compounding Vaccines 98

STAT

NOVEMBER 28, 2023

Belgium drugmaker Argenx said Tuesday that its antibody medicine failed to achieve the goals of a late-stage study for a platelet-destroying autoimmune disorder — a setback in the company’s efforts to expand the drug’s use. Argenx shares were down 12% in early trading. The negative study, called ADVANCE-SC, was the second of two clinical trials involving the Argenx drug called efgartigimod in patients with primary immune thrombocytopenia (ITP), a debilitating condition that

Immunization 305

Immunization Immunity Drug Development 305

Advertisement

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

Pharmaceutical Technology

NOVEMBER 28, 2023

Venture financing for innovative radiopharmaceutical drugs witnessed an approximately 550% increase from $63m in 2017 to $408m in 2023 YTD (year-to-date) total deal value in the US.

98

98

STAT

NOVEMBER 28, 2023

A study questioned colonoscopies as the gold standard of colon cancer screens. Then it raised a furor. Exact Sciences, the maker of Cologuard, touts the accuracy of its colorectal cancer screening tests — but experts want more data. Colonoscopies are time-consuming and unpleasant. How about a yogurt drink instead ?

248

248

Express Pharma

NOVEMBER 28, 2023

Doceree Insights is available for healthcare marketers across the globe Doceree has unveiled its new offering-Insights. Inspired by tools like ChatGPT, this solution aims to transform the way pharma marketers access and interpret data. As the latest addition to the suite of AI-powered tools on the platform, Insights will empower healthcare marketers with a game-changing approach to analytics, making it easier to unravel crucial business insights from marketing campaigns.

102

102

Pharmaceutical Technology

NOVEMBER 28, 2023

The US Food and Drug Administration (FDA) has accepted to review Orexo’s new drug application (NDA) for opioid overdose medication, OX124.

105

105

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharma Times

NOVEMBER 28, 2023

Around 3,000 new cases of mesothelioma are diagnosed in the US every year - News - PharmaTimes

120

120

Pharmaceutical Technology

NOVEMBER 28, 2023

The emergency use listing is based on non-clinical data where the vaccine demonstrated immune responses against variants in SARS-CoV-2.

Vaccines 104

Vaccines Immunization Immunity 104

Outsourcing Pharma

NOVEMBER 28, 2023

Outsourcing Pharma is delighted to invite you to join our not-to-be-missed webinar on one of the most important areas of the industry â patient centricity â and its solutions.

88

88

Pharmaceutical Technology

NOVEMBER 28, 2023

A Phase IIb/III trial studying the company’s immunotherapy izokibep, failed to achieve statistical significance for its primary endpoint

98

98

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

BioPharma Dive

NOVEMBER 28, 2023

Fresh off a $7 billion deal with Roche, the chief executive spoke with BioPharma Dive about this year’s “discordant combination” of major biotech achievements alongside market headwinds.

78

78

Outsourcing Pharma

NOVEMBER 28, 2023

Volunteers with conditions including depression, alcohol use disorder, and anorexia are being sought by Clerkenwell Health, to join its seminal clinical trials.

80

80

Drug Channels

NOVEMBER 28, 2023

I hope everyone enjoyed the Thanksgiving holiday. Now that you’ve stretched your stomach, it's time to stretch your mind with some food for thought. In this issue: A reality check on Express Scripts’ purported “cost-based” pharmacy network Mark Cuban explains how and why the PBM market will change Why two drug prices are better than one Pharmacists sing the retail pharmacy shakeout blues Plus, two Philly legends meet at a cardiology conference!

Drug Pricing 75

Drug Pricing 75

pharmaphorum

NOVEMBER 28, 2023

Putting patients at the centre of innovation starts with clinical trial access Mike.

119

119

Big Molecule Watch

NOVEMBER 28, 2023

Regeneron Pharmaceuticals, Inc. (“Regeneron”) filed a Complaint on November 22 against Samsung Bioepis Co., Ltd. (“Bioepis”) in the U.S. District Court for the Northern District of West Virginia, alleging infringement of 37 patents under the BPCIA based on Bioepis’s submission of an aBLA for SB15, a proposed biosimilar of EYLEA (aflibercept) and Bioepis’s provision of Notice of Commercial Marketing with respect to the same.

Biosimilars 62

Biosimilars 62